GlassScriptPhysician profile
Kathleen E Schiele
NPI 1407850886
$1,539.18
in general payments reported to CMS, 2019-2025
21 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $252 · 2023: $547 · 2024: $290 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $195.87 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $187.79 | 2021-2025 | |
| Glaxosmithkline, LLC. | $166.90 | 2022-2025 | Shingrix, Trelegy Ellipta, Bexsero |
| Novo Nordisk INC | $165.09 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $147.97 | 2021-2025 | Capvaxive, Gardasil 9, Dificid |
| Lilly USA, LLC | $110.95 | 2022-2024 | Mounjaro, Jardiance, Emgality |
| Amgen INC. | $85.28 | 2023-2025 | Evenity, Repatha, Otezla |
| Pfizer INC. | $79.59 | 2021-2025 | |
| Exact Sciences Corporation | $70.24 | 2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $52.67 | 2021-2023 | Trintellix |
| Insulet Corporation | $42.91 | 2025 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.49 | 2022 | |
| Sanofi-Aventis U.S. LLC | $30.64 | 2022-2023 | |
| Astellas Pharma US INC | $30.16 | 2024 | Veozah |
| Phathom Pharmaceuticals, INC. | $26.50 | 2024 | Voquezna |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $25.44 | 2023 | Accrufer |
| Abbott Laboratories | $21.13 | 2023 | Penta |
| Inspire Medical Systems, INC. | $18.61 | 2024 | Inspire |
| Kyowa Kirin, INC. | $16.97 | 2024 | Crysvita |
| Daiichi Sankyo INC. | $16.75 | 2023 | Injectafer |
| Biohaven Pharmaceutical Holding Company LTD. | $15.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Schiele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.